On the possibility of using hyperbaric oxygenation in the treatment of sars-cov-2 infected patients

Pavel Savilov*

The article substantiates the feasibility of including Hyperbaric Oxygenation (HBO) in the treatment of patients infected with SARS-CoV-2. Possible mechanisms of therapeutic influence of hyperbaric oxygen on the course of the pathological process in the body of patients infected with SARS-CoV-2 are considered. The role of urea as a non-specific antioxidant adaptogen in the mechanisms of the therapeutic effect of HBO is considered. The important role of assessing the patient's condition at the time of oxygenation for the correct choice of modes and the number of HBO sessions is shown. It is concluded that it is appropriate to include in the therapy of SARS-CoV-2 infected patients with "soft" HBO regimens (1.3-2.0 ATA, isopression time 45-90 min), regardless of the degree and duration of hypoxemia.

Keywords:

Published on: Nov 19, 2020 Pages: 160-165

Full Text PDF Full Text HTML DOI: 10.17352/2455-2968.000122
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat